Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-03

FDA Approved: DESLORATADINE — Supplemental Application (Natco Pharma USA LLC)

View source ↗

Summary

The FDA approved a supplemental application for desloratadine from Natco Pharma USA LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desloratadine (desloratadine)

Snippet

SUPPL AP for DESLORATADINE (DESLORATADINE)